Wanbury Ltd
₹221.95
(-2.16%)
Sat, 04 Apr 2026, 01:23 pm
Health Technology
Pharmaceuticals: Major
24.5KWanbury Share Price Live Chart
1 Day
0 (0%)
No Result Found
Summary
Market Cap
805
Net Profit
30.53
P/B
14.43
Sector P/E
31.02
P/E
25.18
EV/EBITDA
11.71
Debt/Equity (Industry)
0.23
Interest Cover (Industry)
9.71
ROCE (Industry)
13
RONW (Industry)
12.31
ROE
19.98
ROCE
21.03
Debt/Equity
3.38
EPS (TTM)
12.30
Dividend Yield
0
Book Value
22.16
Interest Cover
1.90
Analysis
all
- Whilst loss making Wanbury has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 16.2% per year.
- Whilst loss making Wanbury has sufficient cash runway for more than 3 years if it maintains the current positive free cash flow level.
- The tenure for the Wanbury board of directors is about average.
- The tenure for the Wanbury management team is about average.
- Wanbury used its assets more efficiently than the IN Pharmaceuticals industry average last year based on Return on Assets.
- Unable to calculate sustainability of dividends as Wanbury has not reported any payouts.
- Unable to evaluate Wanbury's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Wanbury's dividend against the top 25% market benchmark as the company has not reported any payouts.
- Wanbury's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
- Debt is not well covered by operating cash flow (19%, less than 20% of total debt).
Shareholding
| Shareholders | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 | DEC 2024 |
|---|---|---|---|---|---|
| Promoters | 43.07 | 43.09 | 39.63 | 39.76 | 39.76 |
| FII | 0.72 | 0.82 | 1.59 | 1.55 | 0.84 |
| DII | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public | 56.20 | 56.08 | 58.78 | 58.68 | 59.40 |
| Government | 0 | 0 | 0 | 0 | 0 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 329.88 | 282.48 | 252.22 | 235.08 | 204.82 | 187.68 | 140.28 |
| Fibonacci | 282.48 | 264.38 | 253.19 | 235.08 | 216.98 | 205.79 | 187.68 |
| Camarilla | 234.99 | 230.64 | 226.29 | 235.08 | 217.60 | 213.26 | 208.91 |
Pivots Level: Classic
R3
+94.80
329.88
R2
+47.40
282.48
R1
+17.13
252.22
S1
-30.27
204.82
S2
-47.40
187.68
S3
-94.80
140.28
Moving Average
Period
Value
10-EMA
235.15
20-EMA
240.30
30-EMA
241.77
50-EMA
241.47
100-EMA
241.80
200-EMA
243.42
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 05 Feb 2026 | board-meetings | Quarterly Results | |
| 10 Dec 2025 | egm | ||
| 13 Nov 2025 | board-meetings | Quarterly Results | |
| 26 Aug 2025 | agm | ||
| 08 Jan 2025 | egm | ||
| 30 Aug 2024 | agm | ||
| 20 Aug 2024 | agm | Annual General Meeting | 21 Sept 2024 |
| 20 Oct 2023 | egm | ||
| 10 Oct 2023 | egm | Extra Ordinary General Meeting | 11 Nov 2023 |
| 31 Aug 2023 | agm |
Peer Comparison
Wanbury Ltd
Divis Laboratories Ltd
Torrent Pharmaceuticals Ltd
Sun Pharmaceutical Industries Ltd
Dr Reddys Laboratories Ltd
Lupin Ltd
Wanbury Ltd About
Wanbury is engaged in the business of pharmaceutical and related activities, including research.
Industry
Pharmaceuticals - Indian - Bulk Drugs & Formln
Founded
1988
Headquarters
CEO
Employees
Contact
Website
http://www.wanbury.com
shares@wanbury.com; jitendra.gandhi@wanbury.com
Phone
91-22-67942222
Location
BSEL Tech Park B-Wing 10th Flr, Sector 30 A Opp Vashi Rly Stat, Navi Mumbai, Maharashtra, 400703
Deals
| Client Name | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|
| MAGNUM EQUIFIN PRIVATE LIMITED | Sell | 188867 | 250.19 | 16 Sept 2025 |
| SURBHI INVESTMENTS AND TRADING COMPANY PRIVATE LIMITED | Sell | 410000 | 265.65 | 24 Mar 2025 |
| RESONANCE OPPORTUNITIES FUND | Buy | 400000 | 265.66 | 24 Mar 2025 |
| SURESH BHATIA | Buy | 352421 | 283.78 | 31 Dec 2024 |
| BHATIA SURESH | Sell | 352421 | 283.78 | 31 Dec 2024 |
| SURBHI INVESTMENTS AND TRADING COMPANY PRIVATE LIMITED | Buy | 562399 | 148 | 27 May 2024 |
| VIJAY KUNDANMAL CHORARIA | Sell | 599000 | 148 | 27 May 2024 |
| ELIZABETH MATHEW | Sell | 190000 | 133.04 | 09 Jan 2024 |
| MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED | Sell | 202818 | 88.5 | 20 Oct 2023 |
| GANITA TECHNOLOGIES AND SERVICES PRIVATE LIMITED | Buy | 219753 | 52.7 | 04 May 2023 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800